Healthpeak Properties, Inc. (NYSE:DOC) Receives $21.33 Consensus Price Target from Analysts

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have earned an average recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $21.3333.

Several research firms recently weighed in on DOC. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research note on Monday, September 15th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Evercore ISI set a $22.00 price objective on Healthpeak Properties in a research note on Monday, September 15th. Wall Street Zen cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Monday, July 7th. Finally, Wells Fargo & Company reduced their price objective on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 27th.

Healthpeak Properties Stock Performance

Shares of DOC opened at $18.55 on Wednesday. The stock has a 50-day simple moving average of $18.16 and a 200-day simple moving average of $17.91. The stock has a market capitalization of $12.89 billion, a PE ratio of 77.27, a PEG ratio of 3.15 and a beta of 1.09. Healthpeak Properties has a 1 year low of $16.63 and a 1 year high of $23.26. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The firm had revenue of $694.35 million during the quarter, compared to analysts’ expectations of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm’s revenue was down .2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be paid a $0.1017 dividend. The ex-dividend date is Friday, December 19th. This represents a c) dividend on an annualized basis and a yield of 6.6%. Healthpeak Properties’s payout ratio is currently 508.33%.

Insiders Place Their Bets

In other news, CEO Scott M. Brinker acquired 1,490 shares of Healthpeak Properties stock in a transaction on Monday, August 4th. The stock was bought at an average price of $16.83 per share, for a total transaction of $25,076.70. Following the completion of the purchase, the chief executive officer owned 211,906 shares in the company, valued at $3,566,377.98. This represents a 0.71% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders purchased a total of 8,783 shares of company stock valued at $150,129 in the last three months. 0.23% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of DOC. Norges Bank acquired a new position in shares of Healthpeak Properties in the second quarter valued at approximately $140,558,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock valued at $186,405,000 after purchasing an additional 7,872,150 shares during the period. Nuveen LLC acquired a new position in shares of Healthpeak Properties in the first quarter valued at approximately $124,113,000. Invesco Ltd. increased its holdings in shares of Healthpeak Properties by 20.7% in the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock valued at $467,311,000 after purchasing an additional 3,967,830 shares during the period. Finally, Nordea Investment Management AB increased its holdings in shares of Healthpeak Properties by 7,444.0% in the second quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock valued at $67,871,000 after purchasing an additional 3,871,201 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.